12 November 2020 - Antibody treatment co-developed by Canadian scientists has been approved by US FDA.
The U.S. Food and Drug Administration has just given the green light to a promising monoclonal antibody therapy co-developed by Canadian scientists to treat mild to moderate coronavirus infections — a groundbreaking product that's still hasn't been approved by Health Canada for use in this country.